VOR

Vor Biopharma Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth↓ 4/10
  • Value↓ 3/10
Vor Biopharma sales and earnings growth
VOR Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -131.91%
  • FCF Y/Y↓ -48.95%
Vor Biopharma gross and profit margin trends
VOR Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -1645.21%
Vor Biopharma net debt vs free cash flow
VOR Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Vor Biopharma stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks